Program
DAY 1_2021. 9. 3 (Fri)
Grand Intercontinental Seoul Parnas, Seoul, Korea
| Time | Program | Chair / Speaker |
|---|---|---|
| 10:50-12:00 | Poster Session | |
| 12:00-13:00 | Lunch | |
| 13:00-13:20 | Opening Ceremony | Seong Il SEO (President, KPS) |
| Ji Youl LEE (President, APSU) | ||
| Sang Don LEE (President, KUA) | ||
| 13:20-14:25 | Session I: Kidney Cancer I | Jun Hyuk HONG (Korea) |
| Lukman HAKIM (Indonesia) | ||
| 13:20-13:30 | Triggers for Delayed Intervention for Small Renal Masses Undergoing Active Surveillance | Bum Sik TAE (Korea) |
| 13:30-13:40 | Partial Nephrectomy Versus Radiofrequency Ablation for Small Renal Masses: Pros & Cons | Yoon Soo HAH (Korea) |
| 13:40-14:00 | Surgical Management of RCC with Inferior Vena Cava Tumor Thrombus: Conception of Changhai Grading System | Rui Chen (China) |
| 14:00-14:25 | Panel Discussion | Jun Hyun HAN (Korea) |
| Se Yun KWON (Korea) | ||
| Chang Wook JEONG (Korea) | ||
| Edmund CHIONG (Singapore) | ||
| Norio NONOMURA (Japan) | ||
| 14:25-14:35 | Coffee Break | |
| 14:35-15:40 | Session II: Urothelial Cancer I | Hyun Moo LEE (Korea) |
| Teng Aik ONG (Malaysia) | ||
| 14:35-14:45 | What is the Optimal Therapy for BCG Unresponsive High-Risk NMIBC: Intravesical Chemotherapy or Systemic Therapy? | Hyeong Dong YUK (Korea) |
| 14:45-14:55 | Optimal Strategy of Trimodality Therapy: Who, How, and When? | Wan SONG (Korea) |
| 14:55-15:15 | Restaging TURBT Prior to Definitive Locoregional Therapy | Seth LERNER (Baylor College of Medicine, USA) |
| 15:15-15:40 | Panel Discussion | Sang Hoon SONG (Korea) |
| Wan SONG (Korea) | ||
| Sung Dae KIM (Korea) | ||
| Tae Hyo KIM (Korea) | ||
| Seok Joong YUN (Korea) | ||
| Se Young CHOI (Korea) | ||
| 15:40-15:50 | Coffee Break | |
| 15:50-17:00 | Session III: Prostate Cancer I | Cheol KWAK (Korea) |
| Bannakij LOJANAPIWAT (Thailand) | ||
| 15:50-16:00 | How Should We Interpret and Manage PI-RADS 3 Lesions on mpMRI? | Joon Chae NA (Korea) |
| 16:00-16:20 | Focal Therapy: Is It a Standard of Care? | Robert E. REITER (UCLA,USA) |
| 16:20-16:30 | Updates on Immunotherapy Combined with Chemotherapy for Advanced, Metastatic Disease | Sangjun YOO (Korea) |
| 16:30-17:00 | Panel Discussion | Hwang Gyun JEON (Korea) |
| Kyung Hyun MOON (Korea) | ||
| U-Syn HA (Korea) | ||
| Jae Young JOUNG (Korea) | ||
| Jae Hyun RYU (Korea) | ||
| Won Sik JANG (Korea) | ||
| 17:10-17:30 | Satellite Symposium with Janssen Korea | Jeongseok LEE (Janssen Korea) |
| 17:10-17:30 | Optimal Therapeutic Strategy to Improve OS in Advanced Prostate Cancer | U-Syn HA (Korea) |
| 17:30 | Welcome Dinner | |
DAY 2_2021. 9. 4 (Sat)
SETEC Convention Center, Seoul, Korea
| Time | Program | Chair / Speaker |
|---|---|---|
| 09:00-10:05 | Session IV: Kidney Cancer II | Seong Il SEO (Korea) |
| Edmund CHIONG (Singapore) | ||
| 09:00-09:20 | Contemporary Role of Cytoreductive Nephrectomy for Metastatic Disease: When & Why | JEE SOO PARK (Korea) |
| 09:20-09:40 | Updates on Immune Checkpoint Inhibitors for Advanced RCC | Lee Hyung Ho (Korea) |
| 09:40-10:05 | Panel Discussion | Seung Hwan LEE (Korea) |
| Byung Hoon KIM (Korea) | ||
| In Chang CHO (Korea) | ||
| Won Ik SEO (Korea) | ||
| Lukman HAKIM (Indonesia) | ||
| 10:05-10:15 | Coffee Break | |
| 10:15-11:35 | Session V: Prostate Cancer II | Choung Soo KIM (Korea) |
| Jae IL CHUNG (Korea) | ||
| 10:15-10:35 | PSMA Imaging for Management of High-Risk Prostate Cancer and Biochemical Recurrence | Robert E. REITER (UCLA,USA) |
| 10:35-10:45 | Biomarker-Driven Clinical Trials: Promises and Pitfalls | Young Eun YOON (Korea) |
| 10:45-10:55 | Imaging for Castration-Resistant Disease: What is Necessary | Seol Ho CHOO (Korea) |
| 10:55-11:05 | Emerging Options for Non-Metastatic, Castration-Resistant Disease: Fitting in Novel Agents to Current Paradigm | Jongwook PARK (Korea) |
| 11:05-11:35 | Panel Discussion | Sung Kyu HONG (Korea) |
| Chang Hee YOO (Korea) | ||
| Yun Beom KIM (Korea) | ||
| Jong Hyun YOON (Korea) | ||
| Jeong Woo LEE (Korea) | ||
| Teng Aik ONG (Malaysia) | ||
| 11:35-12:00 | KPS BLUE Award and KPS Research Grant | Jae Heon KIM (Korea) |
| 11:35-11:45 | KPS BLUE Award | |
| 11:45-11:50 | Combination of Metformin, mTOR inhibitor and hormonal castration as a novel treatment for Castration Resistant Prostate Cancers | Jung Ki JO (Korea) |
| 11:50-11:55 | Clinical Utility of Prostate Health Index for Prediction of Clinically Significant Prostate Cancer | Wan SONG (Korea) |
| 11:55-12:00 | KPS Research Grant | |
| 12:00-13:00 | Lunch | |
| 13:00-14:10 | Session VI: Prostate Cancer III | Byung Ha CHUNG (Korea) |
| Ji Youl LEE (Korea) | ||
| 13:00-13:10 | Utilization of PARP Inhibitors in Patients with DNA Repair Gene Mutations: A New Era of Precision Medicine? | Won Hoon SONG (Korea) |
| 13:10-13:20 | Adoptive Cellular Therapy for Advanced Disease: An Emerging Treatment Strategy? | Myungsun SHIM (Korea) |
| 13:20-13:30 | Practical Application of Genomic Approaches in Advanced Prostate Cancer: Progress and Promise | Dong Hyuk KANG (Korea) |
| 13:30-13:40 | Oncological Value of Lutetium-177-PSMA Therapy for mCRPC | Hyun Ho HAN (Korea) |
| 13:40-14:10 | Panel Discussion | Bum Sik TAE (Korea) |
| Jin Kyu OH (Korea) | ||
| Kyo Chul KOO (Korea) | ||
| Yun-Sok HA (Korea) | ||
| Hakmin LEE (Korea) | ||
| Jae Heon KIM (Korea) | ||
| See Min CHOI (Korea) | ||
| 14:10-14:20 | Coffee Break | |
| 14:20-15:30 | Session VII: Urothelial Cancer II | Tag Keun YOO (Korea) |
| Norio NONOMURA (Japan) | ||
| 14:20-14:40 | Precision Medicine in Treatment of Muscle Ivasive Bladder Cncer – Are We There Yet? | Seth LERNER (Baylor College of Medicine, USA) |
| 14:40-14:50 | Update on UTUC Management: Perioperative Chemotherapy and LN Dissection | Hakmin LEE (Korea) |
| 14:50-15:00 | Pathology and Molecular Classification of Bladder Cancer: Can It Influence Treatment Decisions? | Jongsoo LEE (Korea) |
| 15:00-15:30 | Panel Discussion | Taek Won KANG (Korea) |
| Jeong Seok HWA (Korea) | ||
| Seung-Ju LEE (Korea) | ||
| Jae Young PARK (Korea) | ||
| Phil Hyun SONG (Korea) | ||
| Won Tae KIM (Korea) | ||
| Bannakij LOJANAPIWAT (Thailand) | ||
| 15:30-16:30 | Session VIII: Benign Prostatic Hyperplasia | Kyung Seop LEE (Korea) |
| Jong Bo CHOI (Korea) | ||
| 15:30-15:40 | Clinical Significance of Urinary Microbiome | Ju Sun SONG (Korea) |
| 15:40-15:50 | The Role and Evidence of Phytotherapy for BPH | Dae Keun KIM (Korea) |
| 15:50-16:00 | Sexual Function Preservation-Surgical Techniques for BPH | Woong Jin BAE (Korea) |
| 16:00-16:30 | Panel Discussion | Moon Ki JO (Korea) |
| Jun Sung KOH (Korea) | ||
| Jae Seung CHUNG (Korea) | ||
| Hongzoo PARK (Korea) | ||
| Seo Yeon LEE (Korea) | ||
| Seung Hwan LEE (Korea) | ||
| 16:30-16:40 | Closing Remark | |
Copyright(C) by 2021 KPS-APSU Joint International Symposium.
All rights reserved.
Secretariat of 2021 KPS-APSU
Gaon Convention Services, Inc.
Address: Room 206, 12, Moraenae-ro 7-gil, Mapo-gu, Seoul, Republic of Korea.
Tel : +82-2-2038-7988 | E-mail : gaonpco@gaonpco.com